Cross-sectional study shows no significant relationship between body mass index and HbA1c levels in type 2 diabetes patients, suggesting other assessments are needed.
Background: The number of diabetes mellitus cases in 2018 in the Special Region of Yogyakarta was the 3rd highest among other provinces in Indonesia with a prevalence of 3.1%. The World Health Organization (WHO) estimates that more than 650 million adults aged ? 18 yeakrs, or 13% of adults worldwide, were obese in 2016. Obesity is a major risk factor for non-communicable diseases, such as cardiovascular disease and diabetes. It was also one of the leading causes of death and disability in 2019." Objective: This study aimed to determine the relationship between body mass index and HbA1c levels in patients with type II diabetes mellitus at Bethesda Lempuyangwangi Hospital. Methods: This cross-sectional study used primary data from 45 patients with diabetes with available HbA1c and BMI measurements. Data were collected using paper-based questionnaires, including informed consent and respondent characteristics. The relationship between the variables was analyzed using the Spearman rho correlation test. Results: Based on the Spearman rho test, there was no significant relationship between body mass index and HbA1c levels (p = 0.670); (p> 0.05). The Kruskal-Wallis mean difference test between body mass index and HbA1c found that there was no significant difference (p = 0.318); (p>0.05). Conclusions: Body Mass Index (BMI) was not significantly associated with HbA1c levels (p > 0.05), indicating that BMI alone may not adequately reflect glycemic control. Therefore, a broader metabolic assessment beyond BMI is needed to evaluate the glycemic status in patients with diabetes.
No takes yet. Share an insight, caveat, or question.
Aurelio et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: